Drug firm Aurobindo Pharma has received final approval from the US health regulator for Meropenem injection used for treatment of complicated skin and related infections, complicated intra abdominal ...
June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...
Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection. The company has received final approval from the US Food & Drug Administration (USFDA) to ...
Brooks Laboratories Limited’s subsidiary Brooks Steriscience Limited, (BSL) has received approval from the United States Food & Drug Administration (USFDA) for Meropenem Injection 500mg per vial and ...
The use of intravenous antibiotics to treat patients at home requires that the therapy be provided safely and cost-effectively. Ideal agents for home use provide the necessary spectrum of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback